CASSAVA SCIENCES INC - FORM 10-Q - EX-32.1 - CERTIFICATIONS OF THE CEO AND THE CFO PURSUANT TO 18 U.S.C. SECTION 1350 - July 29, 2010

Attached files

file filename
10-Q - FORM 10-Q - CASSAVA SCIENCES INCd10q.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - CASSAVA SCIENCES INCdex312.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - CASSAVA SCIENCES INCdex311.htm
EX-10.2 - LETTER AGREEMENT DATED JUNE 24, 2010 - CASSAVA SCIENCES INCdex102.htm
EX-10.1 - 2000 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED AND RESTATED - CASSAVA SCIENCES INCdex101.htm

Exhibit 32.1

CERTIFICATIONS OF THE CHIEF EXECUTIVE OFFICER AND THE CHIEF FINANCIAL

OFFICER PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. Section 1350)

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Remi Barbier, Chairman of the Board of Directors, President and Chief Executive Officer and Peter S. Roddy, Vice President and Chief Financial Officer of Pain Therapeutics, Inc. (the “Company”), hereby certify that to the best of our knowledge:

 

  1.

The Company’s Periodic Report on Form 10-Q for the period ended June 30, 2010, and to which this certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934, and

 

  2.

The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

   Date: July 29, 2010   
   /s/ REMI BARBIER   
   Remi Barbier,   
   Chairman of the Board of Directors,   
   President and Chief Executive Officer   
   /s/ PETER S. RODDY   
   Peter S. Roddy,   
   Vice President and Chief Financial Officer   

Stock widget

Investing forum

CASSAVA SCIENCES INC Reports